When was Odonate Therapeutics, Inc. stock made available for the first time to the public?

The IPO Date for Odonate Therapeutics, Inc. is 2017-12-07. On this 2017-12-07, Odonate Therapeutics, Inc. stock was made publicly available.

Where is the headquarters of Odonate Therapeutics, Inc. stock?

Headquarters of Odonate Therapeutics, Inc. is in US at 3 East 28th Street, New York City, NY 10016.

What industry does Odonate Therapeutics, Inc. belong to?

The Odonate Therapeutics, Inc. belongs to Biotechnology.

Odonate Therapeutics, Inc.

ODTC•PNK

Healthcare

Biotechnology

$22005.00

$5005.00(29.44%)

Odonate Therapeutics, Inc. (ODTC) Company Profile & Overview

Explore Odonate Therapeutics, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Odonate Therapeutics, Inc. (ODTC) Company Profile & Overview

Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York.

SectorHealthcare

IndustryBiotechnology

CEOKevin C. Tang

Contact Information

https://www.odonate.com

332 206 0935

3 East 28th Street, New York City, NY, 10016

Company Facts

137 Employees

IPO DateDec 7, 2017

CountryUS

Frequently Asked Questions

;